Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies
Scarcity of labeled data limits development of deep learning biomarkers in oncology. We develop a two-stage AI model predicting pathological complete response (pCR) to neoadjuvant therapy in breast cancer. The first stage learns the transcriptome from histopathology using 8,742 patients across 32 cancer types, corrobor...
Jungkyu Park, D. Biswas, J. Cappadona et al.
· 0 citations